Is XBIT undervalued or overvalued?
As of 2025-03-15, the Intrinsic Value of XBiotech Inc (XBIT) is -28.71 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.25 USD, the upside of XBiotech Inc is -983.38%. This means that XBIT is overvalued by 983.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -28.71 - -28.71 | -28.71 | -983.38% |
| P/E | (8.80) - (13.64) | (9.88) | -403.9% |
| DDM - Stable | (6.15) - (18.35) | (12.25) | -477.0% |
| DDM - Multi | (3.77) - (9.11) | (5.37) | -265.3% |
| Market Cap (mil) | 99.06 |
| Beta | 0.88 |
| Outstanding shares (mil) | 30.48 |
| Enterprise Value (mil) | -74.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.35% |
| Cost of Debt | 5.00% |
| WACC | 9.00% |